Family Medicine Grand Rounds - PEER Simplified Lipid Guideline Update

Join us for Grand Rounds in Family Medicine on Wednesday, February 7, 2024 from 8:30 to 9:30 a.m. This session will be presented via Microsoft TEAMS only (no in-person attendance).

Dr. Jennifer Young, MD FCFP-EM will present, "PEER Simplified Lipid Guideline Update."

LEARNING OBJECTIVES

The general principal learning objectives for the overall Grand Rounds in Family Medicine program are:

  1. Identify, discuss and appraise pertinent and relevant clinical family practice guidelines and literature;
  2. Identify and discuss current evidence supporting treatment of common conditions in primary care; and
  3. Discuss challenges family medicine physicians face in their current practices

 

Session learning objectives:

At the conclusion of these Grand Rounds, participants will be able to

  1. Identify risk factors for cardiovascular disease and engage in shared decision making with patients;
  2. Appropriately prescribe lipid lowering medications for primary and secondary prevention of cardiovascular
    disease; and
  3. Describe the rationale for targeting treatment rather than treating cholesterol levels to target.

 

25% interaction will be included (Q&A)

Location: MICROSOFT TEAMS webinar or in-person. An electronic appointment with MICROSOFT TEAMS details has been sent to your calendar. If you have not received an appointment, please contact sheena.blasing@sjhc.london.on.ca

To ensure your attendance is recorded, please email sheena.blasing@sjhc.london.on.ca.  Sheena in turn will send you the electronic evaluation form for completion.

This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by Continuing Professional Development, Schulich School of Medicine & Dentistry, Western University for up to 9.0 Mainpro+ credits. Each participant should claim only those hours of credit that he/she actually spent participating in the educational program.

This program has no commercial support.